23andMe Inc.

Company Snapshot

Founded: 2006
Entity Type: Public
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S., U.K, Canada
Corporate Address: 349 Oyster Point Boulevard South San Francisco, California- 94080 U.S. Tel. +1-650-938-6300 www.23andme.com

Company Overview

23andMe is a U.S.-based company established in 2006. The company operates through two primary segments in the direct-to-consumer genetic testing market (DTC GT): Consumer and Research Services and Therapeutics.

Consumer and Research Services: This segment features the Personal Genome Service (PGS), telehealth offerings, and research services. PGS delivers genetic reports on ancestral origins, health risks, carrier conditions, and how genetics can affect responses to medications. The company aims to provide customers with valuable genetic information that supports better health decisions and proactive health management.

Therapeutics: This segment is dedicated to using genetic insights to identify new drug targets and develop innovative therapies. It involves research and development in fields like oncology and inflammatory diseases. Revenue is generated from licensing intellectual property related to these drug targets.

23andMe Inc. In Reports

Personalized Nutrition: Global Markets

Analyze the global personalized nutrition market by component, assessment type, supplement, application and distribution channel, with AI-driven trends and forecasts to 2031.

Mobile Apps for DNA Sequencing: Global Markets

Gain insights into the mobile apps for DNA sequencing market, including size, share, technology adoption, genomics trends, and forecasts through 2030.

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

BCC Research Market Analyst says global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a CAGR of 10.0%.

Company's Business Segments

  • Consumer Services : Personal Genome Service, Telehealth Business, DNA Testing, Genetic Ancestral Origins Services.
  • Research services : Through Research Services, company use their vast Database of Genetic and Phenotypic information provided by consenting customers to discover insights into the Genetic Origins of disease and to identify and validate targets for Drug Development.

Applications/End User Industries

  • Healthcare
  • Biotechnology
  • Pharmaceuticals
  • Academic Researchers
  • Genetic Testing
  • Genetic Discoveries
  • Neurology
  • Hematology
  • Psychiatry
  • DNA
  • Life Sciences
AI Sentiment